Li J, Shi LW, Li K, Huang LR, et al. Comparison of the safety and persistence of immunogenicity of bivalent HPV16/18 vaccine in healthy 9-14-year-old and 18-26-year-old Chinese females: A randomized, double-blind, non-inferiority clinical trial. Vaccine 2023;41:7212-9.
PMID: 39492306